• OPEN AN ACCOUNT
Indian Indices
Sensex
74,294.96 -19.63
( -0.03%)
Global Indices
Nasdaq
51,795.38 312.48
(0.61%)
Dow Jones
7,657.54 84.73
(1.12%)
Hang Seng
65,040.24 903.99
(1.41%)
Nikkei 225
10,816.25 127.78
(1.20%)
Forex
USD-INR
95.66 0.25
(0.26%)
EUR-INR
110.22 0.12
(0.11%)
GBP-INR
128.62 0.00
(0.00%)
JPY-INR
0.62 0.00
(-0.04%)

EQUITY - MARKET SCREENER

Beacon Trusteeship Ltd
Industry :  Finance & Investments
BSE Code
ISIN Demat
Book Value()
92830
INE639X01027
29.4483884
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BEACON
17.26
141.12
EPS(TTM)
Face Value()
Div & Yield %
4.52
10
0
 

sylph technologies ltd
Bal Pharma consolidated net profit declines 33.89% in the March 2026 quarter
May 28,2026
Net profit of Bal Pharma declined 33.89% to Rs 3.59 crore in the quarter ended March 2026 as against Rs 5.43 crore during the previous quarter ended March 2025. Sales rose 2.69% to Rs 84.08 crore in the quarter ended March 2026 as against Rs 81.88 crore during the previous quarter ended March 2025.

For the full year,net profit declined 13.02% to Rs 6.28 crore in the year ended March 2026 as against Rs 7.22 crore during the previous year ended March 2025. Sales rose 2.83% to Rs 311.66 crore in the year ended March 2026 as against Rs 303.08 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales84.0881.88 3 311.66303.08 3
OPM %12.579.33 -10.249.75 -
PBDT6.284.77 32 17.0114.91 14
PBT3.222.59 24 5.935.14 15
NP3.595.43 -34 6.287.22 -13